Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Patients can search for eligible studies via: NIHR 'Be Part of Research' (www.bepartofresearch.nihr.ac.uk) the recommended UK-facing trial finder ClinicalTrials.gov the international registry listing ongoing Phase 3 and cardiovascular outcome studies of retatrutide EU Clinical Trials Information System (CTIS) for trials registered within the European regulatory framework Clinicians wishing to facilitate trial access should contact their institutional Research and Development (R&D) office
Eligible patients can receive a savings card that reduces monthly cost by roughly $100 to $150 [3]
Co-injecting both at the same time means both receptor systems are activated in the same physiological window, mimicking the endogenous GHRH-ghrelin co-release that occurs at the hypothalamic level during natural GH pulses
Abruptly discontinuing the use of the medication may lead to weight gain, requiring continuous medical monitoring
